Dietary Effects on Drug Metabolism and Transport
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 42 (13), 1071-1088
- https://doi.org/10.2165/00003088-200342130-00001
Abstract
Metabolic food-drug interactions occur when the consumption of a particular food modulates the activity of a drug-metabolising enzyme system, resulting in an alteration of the pharmacokinetics of drugs metabolised by that system. A number of these interactions have been reported. Foods that contain complex mixtures of phytochemicals, such as fruits, vegetables, herbs, spices and teas, have the greatest potential to induce or inhibit the activity of drug-metabolising enzymes, although dietary macroconstituents (i.e. total protein, fat and carbohydrate ratios, and total energy intake) can also have effects. Particularly large interactions may result from the consumption of herbal dietary supplements. Cytochrome P450 (CYP) 3A4 appears to be especially sensitive to dietary effects, as demonstrated by reports of potentially clinically important interactions involving orally administered drugs that are substrates of this enzyme. For example, interactions of grapefruit juice with cyclosporin and felodipine, St John’s wort with cyclosporin and indinavir, and red wine with cyclosporin, have the potential to require dosage adjustment to maintain drug concentrations within their therapeutic windows. The susceptibility of CYP3A4 to modulation by food constituents may be related to its high level of expression in the intestine, as well as its broad substrate specificity. Reported ethnic differences in the activity of this enzyme may be partly due to dietary factors. Food-drug interactions involving CYP1A2, CYP2E1, glucuronosyltransferases and glutathione S-transferases have also been documented, although most of these interactions are modest in magnitude and clinically relevant only for drugs that have a narrow therapeutic range. Recently, interactions involving drug transporters, including P-glycoprotein and the organic anion transporting polypeptide, have also been identified. Further research is needed to determine the scope, magnitude and clinical importance of food effects on drug metabolism and transport.This publication has 158 references indexed in Scilit:
- Paracetamol, alcohol and the liverBritish Journal of Clinical Pharmacology, 2000
- Effects of Food on Clinical PharmacokineticsClinical Pharmacokinetics, 1999
- Effect of Grapefruit Juice on the Pharmacokinetics of Microemulsion Cyclosporine and its Metabolite in Healthy Volunteers: Does the Formulation Difference Matter?The Journal of Clinical Pharmacology, 1998
- Drug Interactions with Grapefruit JuiceDrug Safety, 1998
- Drug Interactions with Grapefruit JuiceClinical Pharmacokinetics, 1997
- Bioavailability of Oral Cyclosporine in Healthy Mexican Volunteers: Evidence for Interethnic VariabilityThe Journal of Clinical Pharmacology, 1997
- Influence of Diet and Nutritional Status on Drug MetabolismClinical Pharmacokinetics, 1996
- Grapefruit Juice Alters the Systemic Bioavailability and Cardiac Repolarization of Terfenadine in Poor Metabolizers of TerfenadineThe Journal of Clinical Pharmacology, 1996
- (S )Oxazepam glucuronidation is inhibited by Ketoprofen and other substrates of UGT2B7Pharmacogenetics, 1995
- Interaction between Ethanol and Calcium Channel Blockers in HumansAlcohol: Clinical and Experimental Research, 1992